RHO and neoplasm: Inhibitors of Rho/ROCK or contractility impaired amoeboid movement but had minimal effects on migration in mesenchymal tumour cells thus illustrating that Rho/ROCK signalling/contractility are essential in amoeboid but dispensable in mesenchymal motility [30], [54], [55].